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Abstract 
To do any inference regarding healthcare policy, researchers need secure and 
protected health data which is restricted by privacy laws and interoperability issues. 
Synthetic health data provides a way to generate and investigate data without concerns 
of violating legal restrictions (HIPAA). In this research, we built health insurance and 
loss-of-care modules into a synthetic health data simulator (Synthea) to simulate and 
analyze the impact of health insurance on breast cancer survival rates. We successfully 
reflected real world insurance and loss-of-care impact statistics in Synthea. 
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1 Introduction 
 Health Insurance is a key part of the American healthcare system [1]. Because 
health insurance increases a people’s access to care, it leads to better health outcomes 
for a population [1]. Health insurance is also subject to government policy over its 
implementation [2]. Like all policy, its implementation can be decided through the use 
of data which provide insight on the public health implications and statistics of policy. 
However, health data is subject to barriers to its access, including interoperability issues 
[3] and legal restrictions [4] [5].  Without access to the complete health data that policy 
analysis is based on, researchers and policy makers face difficulties in making fully 
informed conclusions and inferences about health policy, including health insurance. 
 One way to bypass the issues that accessing health data presents is through the 
use of Synthea. Synthea is an open-source health data simulator developed by the 
MITRE Corporation that creates synthetic, yet realistic, health data. It generates 
complete health record histories for each individual patient, allowing for the creation of 
realistic data that can be analyzed and utilized. However, Synthea assumes that patients 
receive all of the care that they need, which is unrealistic. Synthea also does not 
currently feature health insurance or loss-of-care impacts as realsitically modeled 
features. When policy makers and researchers cannot analyze health insurance and 
policy impacts, they cannot make the best decisions for the healthcare industry and the 
Americans who need it. In this MQP, we implemented health insurance and loss-of-care 
modules into Synthea to analyze the impacts that health insurance has on the survival 
rates of breast cancer patients. Breast cancer patients were the population focus used for 
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this MQP as a way to limit the scope for our initial research. We chose survival rates as 
the metric to measure because it is used in real-world policy analysis [6]. The survival 
rates of breast cancer patients are well documented which allowed us to simulate and 
analyze it in Synthea. 
 Our implementation of health insurance in Synthea could be used for future 
health policy and research analysis. We established our newly developed health 
insurance and loss-of-care modules to be reflective of real life and that health insurance 
has a positive impact on survival rates. Health insurance, as an important aspect of 
health policy, is regulated based on health data. Because of the difficulties in accessing 
health data, both for analysis and to measure the impact of different policies, we 
modelled and simulated health insurance in Synthea to find its impact on the survival 
rates of breast cancer patients. 
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2 Background 
 Health insurance in the United States has undergone years of policy change and 
debate. But, like any public policy, the decision over how health insurance should be 
implemented requires a complete understanding of the situation. Understanding the 
complete picture requires using data and analysis. One way that health data determines 
health policy, including with regard to health insurance, is through the use of population 
survival rates. However, researchers struggle to evaluate survival rate data due to the 
barriers of access to health data. Health data barriers include interoperability and 
privacy restrictions which have resulted in incomplete and inaccessible data. One way 
that a researcher could get a complete and realistic picture of health and survival rate 
data is through the use of Synthea, a synthetic health record and patient generation 
software. By simulating a population of health records and health insurance companies, 
realistic, yet synthetic, data could be produced that allows for the analysis of survival 
rates based on different policies. It even allows for the ability to easily change variables 
to see the different impacts that they could have. For the scope of this MQP, we tested 
the impact that health insurance can have on the survival rate of breast cancer patients, 
with the expectation that this research and implementation could expand to include 
more, and eventually all, diseases. To provide a background for the topics of the MQP, 
this chapter describes: 
 Health insurance in the United States and its impacts 
 How researchers use survival rates 
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 The difficulties in accessing real health data 
 Synthea, a health data simulator 
 Breast cancer information 
 The data sources utilized for this research 
 
2.1 Health Insurance in the United States 
 Health insurance exists as a way for patients to overcome the high costs of 
healthcare expenses [7]. These expenses add up and include everything from treatment 
for serious disorders and prescription drugs to routine yearly checkups. For many 
patients, health insurance allows for and encourages medical care. When only a small 
payment is required as opposed to the full fee for care, a patient is far more likely to seek 
and utilize it. Otherwise, health conditions can easily go unchecked for fear of an 
expensive bill [7]. By acting as a way for patients to overcome the high monetary barrier-
for-entry of healthcare, health insurance has vastly expanded the breadth of care that 
patients can receive [8]. 
Origins of Health Insurance in the United States 
 Healthcare costs have risen exponentially over the last century. In 1930, 3.5% 
American GDP was spent on health care, a number which has risen to over 15% today 
[9]. This is logical: considering that healthcare is expensive, labor-intensive, and 
constantly developing new treatments. These costs, coupled with the countless other 
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expenses that healthcare incurs, meant that a health insurance system would be the only 
way for medical care to continue sustainably in the United States. 
Health insurance is a relatively modern phenomenon – only emerging as recently 
as the 1920’s in the United States and, even then, on a very small scale [9]. The first 
health insurance system, known at the time as ‘Hospital Insurance’, was a trial carried 
out at a single hospital in Texas and charged its subscribers a $6 yearly premium [9]. 
Today, these premiums are charged monthly and cost hundreds to thousands of dollars 
per month [10]. The experiment was a success: the hospital’s primary goal, increase cash 
flow, was accomplished. This ‘scheme’ as it was thought of at the time spread quickly to 
other medical institutions. Before long, groups of hospitals created insurance that was 
honored at all participating institutions [9], creating the first health insurance networks 
as we know them today. From the early notion of hospital insurance came the first 
modern health insurance company, Blue Cross, in 1932 [9]. 
Impacts of Health Insurance 
 In 2017, 91.2% of Americans had health insurance while 8.8% did not [11]. This 
uninsured percentage has widely been considered a metric of the health and success of 
the healthcare system because of its indication of a population’s access to healthcare 
[12]. Health insurance has also been credited with improved healthcare outcomes, more 
regular care, and early detection and management of health conditions [12]. Uninsured 
breast cancer patients have even been shown to be 60% more likely to die from the 
disease than insured ones [13] [14]. A breakdown of the percentage of uninsured 
patients losing care is featured in Figure 1 from the Kaiser Family Foundation [15]. 
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Overall as a key component of the healthcare system, health insurance has a positive 
impact on the health of populations. 
Figure 1: Uninsured Patient Loss-Of-Care 
 
Private Health Insurance  
 Private health insurance is the most common type of insurance that patients 
have. 56% of Americans are covered by private insurance, 49% are covered by an 
employer and 7% is purchased directly from an insurance company [16]. With such an 
impact on health outcomes, health insurance’s main source, private insurance, is a key 
component of the United States health system. However, it is also the most expensive 
for patients, leading to the creation of public government insurance. 
Government Health Insurance 
 The two primary government insurances are Medicare and Medicaid. These 
health insurance programs were signed into law by President Lyndon Johnson in 1965 
[17]. Medicare was created in order to provide insurance for those over the age of 65, for 
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whom it is near impossible to get private insurance due to affordability and companies 
rejecting this age group [18]. In 2019, 60.6 million Americans received health coverage 
through Medicare [19]. Medicaid was created as a way for Americans who cannot afford 
private insurance to have access to health care and health coverage [20]. Medicaid 
covers over 70 million Americans [20]. 
In order to qualify for Medicaid, a patient must meet the following requirement: 
 Have a yearly income less than the federal poverty level multiplied by 1.33. The 
federal poverty level is currently $12490 [21] 
In order to qualify for Medicare, a patient must meet one of the following requirements 
[22]: 
 Be over the age of 65 
 Suffer from Amyotrophic Lateral Sclerosis 
 Have Kidney Failure 
Health insurance has had a significant positive impact on the health and survival 
rates of the American population [12]. There have been a multitude of health insurance 
companies in the country, including private insurance and government insurance. With 
the continued expansion of government funded health insurance, both from Medicare, 
Medicaid, and Obamacare, policymakers and researchers have needed to evaluate the 
impacts that health insurance has to institute public health policy. Survival rates are one 
way to measure policy, and health insurance’s, impacts. 
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2.2 Survival Rates as a Metric for Measuring Policy Impacts 
 Survival rates have been used to measure the burden and impact of disease for 
centuries [6]. These include analyses like determining the leading causes of death in the 
United States as well as age-specific mortality rates that can influence policy decisions 
[6]. Survival rates are simply calculated as the number of deaths divided by the size of 
the sample [23]. Survival rates are based on health data, however analyzing this data 
can be incredibly difficult because of the barriers to its access. 
 
2.3 Health Data Barriers and Concerns 
 Despite the benefits that sharing health data would provide, both to researchers 
and policy makers for data analysis, health data is subject to privacy, legal, and 
interoperability issues that prevent its accessibility [4]. These barriers to health data are 
characterized by HIPAA, the Health Insurance Portability and Accountability Act, 
which enforces patient protections on health data [4]. Health record formats differ 
between each hospital, resulting in a lack of interoperability and inability to gather and 
integrate large amounts of data for analysis [24].  
Legal and Privacy Regulations 
Health data is subject to legal restrictions to protect patient the privacy. HIPAA, 
“The Standards for Privacy of Individually Identifiable Health Information (“Privacy 
Rule”) establishes, for the first time, a set of national standards for the protection of 
certain health information.” [25]. HIPAA makes it very difficult to share data and do 
research. Within individual hospitals, a hospital has control and access over their small 
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sample of data. However, an outsider academic researcher is barred from accessing the 
data, even for a rigorous, controlled study because of HIPAA [5]. However, the data that 
exists holds huge potential for research and doctors to determine policy and treatment 
impacts. Because of privacy and legal restrictions preventing the use of health data in 
research studies, it can be difficult for policy makers and researchers to analyze health 
data for information about survival rates. 
Interoperability 
 Health data is also difficult to collect in a large-scale and complete format 
because of interoperability issues. Issues include patient identification (for cross-
hospital health records) with studies showing that “up to one in five patient records are 
not matched even within the same health care system.” [3] and “as many as half of 
patient records are mismatched when data is transferred between health systems” [3]. 
Without the ability to access patients’ complete health records, especially when 
amplified when trying to analyze an entire population, it can be near-impossible to have 
full and accurate datasets. A federal patient identification system, while proposed, has 
faced backlash because of HIPAA [3]. Another interoperability issue is the lack of 
technological and record format standards across healthcare facilities. Without 
consistent record formats, both digital and paper, data exchange between different 
healthcare facilities can be near-impossible [3]. Complicated data transactions tend to 
fail, posing additional barriers to the flow of information [3]. Analyzing data relies on a 
complete and accurate dataset, a requirement which is difficult to create and access with 
real-world health data. 
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While the healthcare industry continues to struggle with data issues, many 
organizations are making an effort to ease interoperability and privacy issues: to 
improve the efficiency of care and allow for the analysis for complete data. One such 
solution for providing complete datasets  is the open-source health care modeling and 
simulation software, Synthea. 
 
2.4 Synthea 
Synthea is an open-source health data modeling simulator developed by the 
MITRE Corporation. It simulates and outputs synthetic but realistic health records at an 
individual level for each patient in a population, modeling everything from diseases and 
procedures to wellness encounters. It uses real-world incidence rates, conditions, and 
treatment plans based on real diseases and illnesses. Medications, procedures, or simply 
time, result in each disease’s conclusion or, potentially, the person’s death, reflecting the 
real-world. All of the demographic data that is used to generate synthetic people also 
directly reflects real life, with real incomes and job levels. 
Synthea as a Solution to Health Data Barriers 
 Synthea’s synthetic data is free from all of the issues associated with real health 
data. There are no privacy or legal concerns because Synthea creates synthetic data. 
Because it simulates a synthetic person’s life from birth to death, Synthea provides 
complete health records with no interoperability issues. As a realistic, yet synthetic, 
alternative to real health data, Synthea is able to overcome the barriers to real data, 
allowing for the analysis complete health records. The data is highly useful to analyzing 
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treatments, medications, and, of course, survival rates. However, Synthea does not 
currently feature one critical component of the real-world healthcare system: health 
insurance and the loss-of-care impacts associated with it. 
Health Insurance and Loss-of-Care in Synthea Prior to the MQP 
 In the iteration of Synthea prior to this MQP, every person receives all of the 
healthcare that they need for free. There are not realistic health insurance or loss-of-care 
modules programmed in Synthea. Of course, this is unrealistic because a person’s health 
insurance and income has a significant impact on a person’s access to healthcare [26].  
In the real world, a person must be able to: afford private insurance, have 
employer-sponsored insurance, or qualify for Medicare/Medicaid to have insurance. If a 
person does not meet any of these thresholds, then they will not receive health 
insurance. In this case, all medical bills will be out-of-pocket, and, in many cases, the 
person will not be able to afford or receive the treatment and care that they need [26]. 
When a person does not receive the requisite healthcare, then it is more likely that they 
will continue to suffer from any conditions and, eventually die [26]. One goal of this 
MQP, in order to analyze Synthea’s health insurance and survival rate outputs, is to 
implement a realistic health insurance system and loss-of-care impacts on survival 
rates. 
 
2.5 Breast Cancer 
 This MQP focuses on breast cancer patients as the scope of the population we 
analyzed and tested. Further research would be to expand our implementation of health 
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insurance impacts to all diseases in Synthea. In order to do research with a pilot 
program and have a specific dataset to work with, a single disease, breast cancer, was 
chosen. 
 We chose breast cancer because it has a high incidence rate at 12% of all females 
in their lifetimes [27], is an important social and policy topic, and there is  survival rate 
and insurance information available to analyze Synthea’s outputs as accurate. 
 An important aspect of our results is understanding the staging and 
characteristics of breast cancer. Breast cancer diagnosis includes two staging 
techniques: TNM staging and Location-based staging. Synthea outputs its staging 
diagnoses as TNM staging, however the most reliable data sources online presented its 
information in the location-based staging method.  
 The TNM Staging method is defined as the following [28]: 
o Stage I 
o Stage II 
o Stage III 
o Stage IV 
 The Location-based staging is based on where in the body the cancer has 
metastasized : 
o Localized 
o Regional 
o Distant 
Health insurance impacts survival rates, and specifically breast cancer survival 
rates. For instance, one study showed that uninsured breast cancer patients were 60% 
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more likely not to survive the disease than insured ones. We used these data sources to 
tune Synthea’s health insurance, breast cancer, and loss-of-care impacts as reflective of 
real life. 
 
2.6 Data Sources 
 To verify and tune Synthea’s breast cancer, health insurance, and loss-of-care 
impact outputs, we needed the real-world data. “The Surveillance, Epidemiology, and 
End Results (SEER) Program of the National Cancer Institute (NCI) is an authoritative 
source of information on cancer incidence and survival in the United States” [29]. 
SEERS datasets were the primary source of comparing real-world data to Synthea 
outputs for tuning and seeing how well it reflected the real world. The Center for Disease 
Control (CDC) even references SEER data as one of the primary sources of cancer 
statistics [30]. Our other two data sources used were studies conducted on SEER data, 
so indirectly all of our sources depended on SEER data. The three datasets and their 
reliability and underlying datasets are described as follows. 
The real data that was gathered for verifying and comparing Synthea’s outputs 
was received from: 
 SEERS, the National Cancer Institute. 
o The first Source of Data is from SEERS which provided information on 
Location-based staging distributions and the survival rate by stage-at-
diagnosis. It also detailed the overall survival rate of breast cancer 
patients. 
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 The Study: Breast Cancer Stage Variation and Survival in association with 
insurance status and socioeconomic factors in US women aged 18-64 years Old 
o This study was based off of the Surveillance, Epidemiology, and End 
Results 18 Registries Database (SEER 18). The information used from this 
study was the distribution of insurance statuses among breast cancer 
patients. It also provided information on the increased likelihood of death 
if a patient does not have insurance. Insurance data became available in 
SEERS in 2007, which the study utilized and aggregated.  
o The study found that uninsured breast cancer patients were 60% more 
likely to die than insured ones with a survival rate of 80.4% for uninsured 
patients. With a sample of this size, and 97,055 patients diagnosed with 
breast cancer in 2007 and 2008, it is an encompassing dataset. Because it 
is based on an analysis of SEERs data, which is highly regarded, it can be 
considered reliable. 
 Breastcancer.org, an organization that aggregates SEERS data. 
o As a source that aggregates data in an easy to understand format, 
breastcancer.org used SEERs datasets in order to generate information 
about the survival rate by stage-at-diagnosis. 
Each of the used datasets aggregates information about the stage-at-diagnosis 
and survival rates of breast cancer patients. In these aggregate datasets, staging 
distributions and survival rates do not change over time and are instead based solely on 
the initial stage of diagnosis, just as Synthea is. Each dataset has a similar, but slightly 
differing underlying population on which it is based. We also verified that each dataset 
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is reliable and realistic because the data that our hypothesis was tested on from Synthea 
needed to accurately reflect the real world. Table 1 features a breakdown of each source’s 
underlying population. 
Table 1: Underlying Population of Each Used Dataset 
Metric SEER Dataset Breast Cancer 
Insurance Study 
Breastcancer.org 
Information 
Patient Type Breast Cancer Only Breast Cancer Only Breast Cancer Only 
Region United States United States United States 
Population Size 516,079 52,048 497,931 
Gender Female Female Female 
Races All All All 
Year Range 2009 - 2015 2007 - 2008 2007 – 2013 
Age Range All 18 - 64 All 
 
  
As evidenced by this chapter, because health insurance has had such a significant 
impact on the healthcare industry, it has become a key component of American health 
policy. For policy makers and researchers to make informed healthcare decisions, they 
need health data – which is subject to privacy, legal, and interoperability barriers that 
prevent its access. To overcome these barriers, a person could use Synthea to generate 
complete and realistic data that is free from the issues of real data. For this MQP, we 
implemented health insurance and loss-of-care in Synthea so that we can generate 
populations for analysis on how health insurance impacts survival rates. For now, we 
focused on breast cancer with the expectation that this research could expand to all 
other diseases in Synthea.  
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3 Research Proposal 
Health insurance has been a central part of the American health policy and 
healthcare industry for over 50 years. Policy makers make informed decisions about 
money and resource allocation for healthcare and health insurance. Resource allocation 
is based on analyzing the efficacy of current policies using metrics such as survival rates 
[31], which is positively impacted by health insurance [32]. Recently, policy makers in 
the United States have been focused on health insurance when crafting health policy 
[33]. Policy makers need to have access to all of the data available in order to assess the 
actual survival rates and the reasons for it. Health data becomes especially crucial when 
it comes to targeting a specific cause of mortality, such as infant mortality, maternal 
mortality, or breast cancer [34] [35]. Health data provides insight to the causes and 
history of survival rates [36] but is difficult to access, both for researchers and even 
policy makers. Health data, that survival rate analysis is based on, is subject to legality 
and privacy regulations imposed by HIPAA [37]. Another health data barrier is 
interoperability issues, in which healthcare facilities use incompatible record formats, 
leading to incomplete health records [38]. Accurate and complete health data is critical 
for policy makers to analyze the impacts of health policy on metrics such as survival 
rates [39]. 
We simulated health insurance and its impact on the survival rates of a 
population. Due to the difficulties in accessing the health data that survival rate analysis 
is based on, we used Synthea, a health data simulator created by the MITRE 
Corporation. Synthea generates realistic, complete, yet synthetic health data that is free 
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from the concerns of real health data. However, Synthea does not currently feature or 
model realistic health insurance or loss-of-care survival impacts. In this MQP, we added 
health insurance and loss-of-care to Synthea to generate data about its impact on 
survival. To limit the scope of our population, we chose breast cancer as our focus. We 
chose breast cancer because of its high prevalence, frequent treatment needs, and the 
information available online. Through these resources, we were able to obtain the data 
necessary to make our conclusions. Overall, our research question is:  How does 
Health Insurance coverage impact the Survival Rates of Patients with 
Breast Cancer? 
We answered this question by: 
 Implementing health insurance and loss-of-care impacts in Synthea. (Figure 2) 
 Testing that Synthea’s breast cancer, insurance coverage, and loss-of-care impact 
outputs are reflective of real-world SEERS data. This is Hypothesis 1, serving the 
purpose of establishing the validity of Synthea’s data for inference. (Figure 2) 
 Comparing Synthea’s survival rate outputs for patients with insurance and 
patients without insurance. This is Hypothesis 2 and established the significance 
of health  insurance on the survival rates of breast cancer patients. (Figure 3) 
 
3.1 Hypothesis 1: Determining the closeness of Synthea’s breast cancer and 
health insurance outputs with real-world data 
To make any conclusions about Synthea’s outputs, we must know that closely 
reflects real-world data. We ascertained closeness by comparing the synthetic data with 
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real world data. Based on our comparisons, we determined whether or not Synthea’s 
outputs align or if they have a significant difference. Without confirming that Synthea’s 
health insurance outputs reflect the real world, we would not have been able to make 
any reliable inferences. 
We compared Synthea’s outputs with real world data metrics. These metrics can be 
separated into three main categories: 
 
We used the available real data and studies based on real data in our analysis of 
Synthea’s outputs. We compared the outputs of the distribution of breast cancer stages, 
The survival rate by-stage, the overall survival rates, the impact of loss-of-care on a 
person’s prognosis, and if their insurance status reflects the real world. 
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3.2 Hypothesis 2: Survival rates for breast cancer patients remain 
unchanged with or without insurance 
 We tested the hypothesis that survival rates of patients will not differ depending 
on their health insurance status. The survival rate was determined by dividing the 
number of breast cancer survivors of a Synthea population output by the number of 
Figure 2: Implementation and Hypothesis 1  Breakdown 
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breast cancer deaths. The statistical formatting we used to analyze this hypothesis is as 
follows: 
 H0 : μI <= μU 
 H1 : μI > μU 
Where μI is the average survival rate of insured breast cancer patients and μU is the 
average survival rate of uninsured breast cancer Patients. 
The data was gathered through two simulations of Synthea in which, using real 
demographic data, patients were generated with individual incomes for each year. Based 
on this income, a person may be able to afford private insurance or qualify for Medicaid. 
In the event that a person falls in the range between the cost of private insurance and 
Medicaid qualification, they will have no insurance and will thus not receive healthcare. 
Throughout a given year, a person incurs costs, including healthcare costs (if they have 
no insurance), monthly premiums, and copays until, at one point, they will not be able 
to afford health insurance or healthcare. After not receiving requisite healthcare, such as 
chemotherapy or a lumpectomy, they will have a higher likelihood of death based on 
mortality rates for not receiving certain care. These survival rates were collected from 
SEERS, the National Cancer Institute and Cancer.net. 
For this hypothesis, we compared the survival rates of those patients who had 
health insurance against the survival rates of patients who had no insurance. We used 
the survival rates of each population as our test statistic. To test this hypothesis, we 
generated two sample populations of size 1000 in Synthea. One population received 
universal, free health insurance and the other had no insurance available. Based on a 
two-sample pooled proportion p-test, we determined if there is a significant difference 
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between the two populations’ survival rates, allowing us to potentially reject Hypothesis 
1 and conclude that health insurance does have a positive effect on the survival rates of 
breast cancer patients in Synthea. 
 
3.3 Breast Cancer Focus 
 In this MQP, we focused on breast cancer patients as our scope of population. 
Limiting our population to breast cancer patients allow us to focus on a well-
documented disease [40]. Breast cancer is a significant disease in the modern world 
with incidence rates of about 12% of all women throughout their lifetimes [41]. The data 
Figure 3: Hypothesis 2 Survival Rate Testing Breakdown 
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that provides information on breast cancer’s staging, survival rates, and insurance 
statistic are in the range from 2007 – 2015. For these reasons, we used breast cancer 
patients from 2007 - 2015 as the population scope for this MQP. 
The next chapter will describe our methodology and step-by-step process in 
implementing health insurance and loss-0f-care survival impacts in Synthea. 
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4 Methodology 
To address our research question, we needed to add a key missing component to 
Synthea: Health insurance. As it was prior to the MQP, Synthea held a very basic health 
insurance system that was based on enumerations of either Medicare, Medicaid, private 
insurance, or no insurance. It did not take into consideration any costs, copays, or 
deductibles of healthcare. Through this MQP, we implemented a more robust health 
insurance system, which includes real companies and allows for copays, monthly 
premiums, and other real-world insurance costs. Simply adding health insurance to the 
current implementation of Synthea would not be enough: because patients would still 
receive all the healthcare they need no matter their insurance status. To account for 
uncovered healthcare, we also implemented a loss-of-care feature that tracks the care 
that a patient should have received and how it impacted the patient’s prognosis. Finally, 
we tuned Synthea so that its outputs would reflect real-world data, until we could assess 
it as accurate. The data we used to tune Synthea includes statistics about the insurance 
distributions of breast cancer patients as well as the survival rates of patients without 
insurance. Overall, our methodology in this MQP consisted of the following steps: 
1. Implement health insurance in Synthea. 
2. Implement loss-of-care survival impacts in Synthea. 
3. Tune Synthea’s health insurance and loss-of-care modules to reflect the real 
world. 
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4.1 Implementing Health Insurance in Synthea 
 To prepare Synthea to produce the requisite data, we removed the insurance 
enumerations and redefined the way that a person interacts with and receives health 
insurance. Throughout a person’s simulated life in Synthea, they now enroll yearly in 
health insurance based on factors such as qualifying for Medicare or Medicaid and the 
affordability of private insurance. A person qualifies for Medicare if they are over the 
age of 65 and qualify for Medicaid if they are pregnant, have end-stage-renal-disease, or 
their income is less than the federal poverty level multiplied by 1.33; If the person 
qualifies for either of these programs, they automatically receive it. Otherwise, they will 
randomly choose any available private insurance that they can afford. Affordability is 
based on the cost of the payer’s monthly premiums multiplied by 12 added to the 
deductible. If this value is greater than the person’s income, which is generated based on 
real socioeconomic and demographic data, then they cannot afford the payer. We are 
making the assumption that every person is willing to spend the entirety of the yearly 
income on healthcare. We also assume that all private payers unconditionally accept any 
customer that can afford them. In the event that the person cannot afford any of the 
available insurance, then they receive no insurance. Figure 4 displays a sequence 
diagram describing the different ways that a person receives certain insurance in 
Synthea. 
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Figure 4: Sequence Diagram of Receiving Different Insurance 
Choosing a person’s insurance for the year is based on the 
HealthInsuranceModule class which features two methods: process() and 
determineInsurance(). The flow of time in Synthea is based on a time-step, which is a 
pre-defined period of time in which Synthea periodically executes. For every time step of 
Synthea, the HealthInsuranceModule uses process() for each person.  Process() checks 
to see if the person needs to enroll in a new year’s insurance and, if so, the person will 
enroll. In this case, the strategy design pattern was used in order to call a PayerFinder, 
which allows for a predefined insurance selection algorithm. In this iteration, we 
implemented an algorithm in which the person chooses random, affordable, insurance. 
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 We implemented a new Payer class that sets, tracks, and processes all payer-
related activities. The Payer class generates all payers that will exist in the simulation 
based on an input file. This input file sets the important attributes of each payer, 
including their name, the states they operate in, their deductible, their copay amount, 
their monthly premium, and whether they are private or government-owned. An 
additional Payer is generated from outside of the input file which acts as a null 
placeholder for no insurance and has all values set to zero. All statistics for each payer 
are tracked throughout the simulation, including the amount of expenses they covered, 
the amount of expenses they did not cover, the number of covered and uncovered 
encounters/medications/procedures/immunizations, the number of unique customers, 
the QOLS average of all of their customers by year, and the number of member months 
covered. 
 Whenever an encounter occurs, a Claim is created in which costs are calculated 
and assigned to the participating parties. When the encounter ends, the total cost of the 
encounter, including any associated procedures, medications, and immunizations is 
determined based on realistic costs. The person is then assigned the cost of the copay, or 
the full cost of the encounter if their payer does not cover it. The expenses that the 
person must pay are added to their annual incurred health costs. This metric is useful 
when determining if a person can still afford healthcare throughout the year. The payer 
is then assigned the rest of the cost of the claim that the person did not cover. 
 Throughout the year, a person will incur healthcare expenses including copays, 
full encounter costs, and monthly premiums. As expenses are incurred, they are added 
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to the person’s yearly healthcare expenses which may, at one point, exceed their income. 
In the event that this occurs, they will immediately switch to no insurance. 
 The relevant features of the implementation of the payer class can be seen in the 
Class Diagram displayed in Figure 5. 
 
Figure 5: Synthea Class Diagram of Relevant New Insurance Features Added 
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 Figure 5 shows the relevant classes, functions, and relationships that were added 
to Synthea. The following Class Diagram displayed in Figure 6 shows its structure prior 
to implementation. 
 
Figure 6: Synthea Class Diagram of Relevant Components Prior to New Features 
  
 To analyze health insurance in each simulation, we added an output file, 
payer_transitions.csv, to Synthea. Payer_transitions.csv details the health insurance 
held at every year of every patient’s life. With a clear-cut described health insurance 
status for every given year, we gained the ability to determine exactly how many years 
each type of insurance was utilized for, giving us an overall percentage of the 
distributions of insurance types. Payer_transitions.csv would become useful for 
associating and tuning Synthea’s outputs and analyzing the MQP’s results. 
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To view the entire implementation, including code and a detailed explanation, 
visit https://github.com/synthetichealth/synthea/pull/527.  
At this stage of Synthea’s implementation, having no insurance and not receiving 
healthcare does not actually affect a person’s survival rates. This was the next step to 
implement. 
 
4.2 Implementing Loss-Of-Care and its Impact on Survival 
 In order for a person’s insurance to have a real impact on their simulated lives, 
healthcare that is not covered must effect their survival probability. In order to 
implement this, a new health record for each person was created that acts as a tracker of 
what care the person should have received but did not. This health record is known as 
the Uncovered Health Record. In this case, if someone needed chemotherapy, but they 
did not have insurance and could not afford the procedure, then that treatment would 
go into the Uncovered Health Record. 
 Throughout a person’s simulated life, Synthea will check their Uncovered Health 
Record for treatments that the person should have, but did not, receive. Based on real 
prognosis rates, each uncovered treatment will result in a higher likelihood of a person’s 
death. Through research, we found that, according to the National Cancer Institute, 
based on SEERs information, uninsured breast cancer patients have a 60% higher 
likelihood of death than insured patients [13]. According to his dataset, the overall 
uninsured population survival rate should be around 80.4% [13]. We started by 
instituting a baseline 60% likelihood of death if a treatment was in the Uncovered 
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Health Record, but found that this resulted in far too low survival rates of around 56%. 
We then hit an issue where a person would constantly have a 60% likelihood of death for 
every Synthea timestep. So we needed to fix the issue by having Synthea calculate an 
increased likelihood of death only once for each missed treatment. We also needed to 
fine tune the percentage of death so that it would reach approximately 80.4%. With 
multiple simulations, each tweaking the likelihood of death, we eventually settled on 
probabilities of death that resulted near target 80.4% survival rate. The overall survival 
rate that Synthea’s uninsured breast cancer patients experience after tuning was 81.0%. 
With loss-of-care implemented, we needed an understandable data format that 
Synthea could output to describe its impacts in the simulation. We added a 
deathStatistics.csv output file that describes the following attributes of each patient: 
 Their birthdate 
 The date that they got breast cancer 
 The Stage-at-diagnosis of their cancer 
 Whether they survived the cancer 
 Their date of death 
 Their cause of death 
o Could only be: Natural Causes, Uncovered Treatment, or Inevitable 
Breast Cancer Death 
 Whether they died due to uncovered treatment (loss-of-care) 
 How many years after getting breast cancer they survived for 
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The deathStatistics.csv output file allowed us to analyze each of these attributes, 
gaining an understanding of how many people died due to loss-of-care impacts, how 
long people survived for, and what stages they were diagnosed at. These attributes 
became useful for tuning and testing its association with real data and analyzing the 
results of the MQP. Now that we implemented loss-of-care so that it affects a person’s 
likelihood of death, we needed to implement real-world health insurance levels. 
 
4.3 Implementing Real-World Health Insurance Levels 
 With payers and loss-of-care implemented and instituted in Synthea, the next 
step was ensuring that a population displays a distribution of health insurance statuses 
that is reflective of the real world. The implementation started with finding the real-
world distributions of health insurance among breast cancer patients. The breast cancer 
health insurance study provided the following real-world data in Table 2 based on an 
aggregate of the SEERS 18 dataset. 
Table 2: Breakdown of Insurance Distributions of Real-World Breast Cancer Patients 
  
 
 
 
For Synthea to reflect these percentage breakdowns, we needed to fine-tune the 
cost of its private insurance, which acts as the only barrier for patients to receive it. 
Real Data 
Insurance 
Percentage breakdown 
of each insurance status 
    
Private Insurance 86.00% 
Medicaid 11.60% 
No Insurance 2.40% 
40   Modeling Health Insurance in Synthea 
Based on patients’ individual, and realistic, incomes, the may or may not be able to 
afford a payer, as previously described. We started with a baseline cost of a $1000 
deductible, $55 copay, and $1000 monthly premium, but found that this resulted in far 
too high of a private insurance incidence rate. However, we did find that, regardless of 
any costs we input, the percentage of patients with Medicaid never changed and was 
highly consistent with the real-world Medicaid rate. This makes senses because the 
qualification for Medicaid is predefined at 1.33 multiplied by the federal poverty rate, 
$11000, and, since the patients have realistic income distributions, the amount 
qualifying for Medicaid naturally follows. As we gradually tweaked and adjusted 
insurance costs in order to tune Synthea to produce outputs reflective of the real world, 
we eventually settled on a $1000 deductible, $55 copay, and $1400 monthly premium. 
The breakdown of Synthea’s insurance outputs and its comparison to real data is 
described in Table 3 and Table 4. 
 
Table 3: Synthea's Tuned Insurance Incidence Distribution 
Synthea Output 
Insurance 
Number of Years of Insurance 
Use 
    
Private Insurance 72850 
Medicaid 9758 
No Insurance 2017 
Total Years 84625 
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Table 4: Comparison of Synthea's Insurance Distributions with Real-World Data 
 Real Data Synthea Data 
Insurance 
Percentage 
breakdown of each 
insurance status 
Percentage breakdown of 
each insurance status 
Private Insurance 86.00% 86.09% 
Medicaid 11.60% 11.53% 
No Insurance 2.40% 2.38% 
 
With health insurance, loss-of-care, and data tuning implemented in Synthea, we 
were able to associate Synthea’s outputs with real data and make conclusions on it so as 
to answer our research question. To answer the question, How Does Health Insurance 
Impact Survival Rates of Breast Cancer Patients? we needed to closely associate 
Synthea’s outputs to be reflective of real-world data. We achieved this goal by obtaining 
the real-world data necessary to compare with and tune Synthea’s outputs. Once 
Synthea was verified as reflective of the real world, we made conclusions about how 
different health insurance levels and policies affected the overall survival rates of breast 
cancer patients. To achieve this, we generated two different health insurance status 
populations from Synthea: a population with full insurance coverage and one with no 
insurance. We then compared the two samples with a statistical significance test, using 
two-sample proportion p tests. Next, we generated a Synthea population with 
realsitically tuned insurance distributions (private insurance, government insurance, no 
insurance) and compared them to the real data and Synthea’s outputs. 
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5 Results 
 We used Synthea to generate two populations of 1000 patients. One population 
had full insurance and one population had no insurance. We started by comparing 
Synthea’s breast cancer and insurance output data with real world data to assess how 
closely it reflected real life. When we were confident in its similarities, we ran Synthea to 
generate datasets detailing each patient’s survival and health insurance status. We 
aggregated these outputs into percentages for comparison and statistical analysis in our 
hypotheses. 
 
5.1 Result 1: Verifying Synthea’s Outputs 
To ensure that our hypotheses are valid, Synthea’s outputs must be established to 
closely reflect real-world data. In comparing Synthea’s outputs, we needed to analyze 
the following metrics: 
1. Synthea’s breast cancer outputs regarding cancer stage diagnoses and survival 
rates. 
a. Compare the percentage of incidence of stages in Synthea and real data. 
b. Compare the survival rates by-stage in Synthea with real data. 
c. Compare the overall survival rates of breast cancer patients in Synthea 
with real data. 
2. Compare Synthea’s overall survival rate of a population without insurance with 
real data. 
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3. Compare Synthea’s levels of health insurance with real data. 
 
Real-World Data Used 
Each of the datasets used in verifying Synthea’s outputs aggregates information 
about the cancer stage-at-diagnosis and survival rates of breast cancer patients. In these 
aggregate datasets, survival rates per-stage do not change over time and are instead 
based solely on the initial stage of diagnosis, just as Synthea is. Each dataset has a 
similar, but slightly differing underlying population on which it is based, the differences 
of which are described later in this section. We also needed to verify that each dataset is 
reliable and realistic because the data that our hypothesis were tested on from Synthea 
must accurately reflect the real world. What follows is a breakdown of each source’s 
underlying population and its reliability as a valid data source. 
Dataset: SEERS 
The first Source of Data is from SEERS which provided information on the 
percentage of stages-at-diagnosis for Location-based the survival rate by stage-at-
diagnosis. It also detailed the overall survival rate of breast cancer patients. It is based 
on the following underlying population in Table 5. 
Table 5: SEERS Dataset Underlying Population 
Patient Type Breast Cancer Only 
Region Throughout United States 
# Of Patients in Population 516,079 
Gender Female 
Races All 
Years Range 2009 – 2015 
Age Range All 
44   Modeling Health Insurance in Synthea 
 
“The Surveillance, Epidemiology, and End Results (SEER) Programs provides 
information on cancer statistics in an effort to reduce the cancer burden among the US 
population” [42]. It is supported by both the Surveillance Research Program and the 
National Cancer Institute and is one of the CDC’s official federal cancer registries [43]. 
Dataset: Breast Cancer Stage Variation and Survival in association with 
insurance status and socioeconomic factors in US women aged 18-64 years 
Old study 
This study was based off of the Surveillance, Epidemiology, and End Results 18 
Registries Database (SEER 18). The information used from this study was the 
distribution of insurance statuses among breast cancer patients. It also provided 
information on the increased likelihood of death if a patient does not have insurance. 
Insurance data became available in SEERS in 2007, which the study utilized and 
aggregated. 
The study found that uninsured breast cancer patients were 60% more likely to 
die than insured ones with a survival rate of 80.4% for uninsured patients. With a 
sample of this size, and 97,055 patients diagnosed with breast cancer in 2007 and 2008, 
it is an encompassing dataset. Because it is based on an analysis of SEERs data, which is 
highly regarded, it can be considered reliable. It is based on the following underlying 
population in Table 6. 
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Table 6: Insurance Status Dataset Underlying Population 
Patient Type Breast Cancer Only 
Region United States 
# Of Patients in 
Population 
52,048 
Gender Female 
Years Range 1/1/2007 – 12/31/2008 
Age Range 18 - 64 
 
Dataset: breastcancer.org 
 As a source that aggregates data in an easy to understand format, 
breastcancer.org used SEERs datasets in to generate information about the survival rate 
by stage-at-diagnosis. It is based on the following underlying population in Table 7. 
Table 7: Breastcancer.org Dataset Underlying Population 
Patient Type Breast Cancer Only 
Region United States 
# Of Patients in Population 497,931 
Gender Female 
Range of Time 2007 - 2013 
Age Range All Ages 
 
Synthea Output Data 
In obtaining data from Synthea, we used the following run command for every 
dataset simulated: 
 ./run_synthea -p 1000 -g F -m breast_cancer 
This command generates a population of size 1000 patients, all of which are 
female, with breast cancer as the only disease in the simulation. Its underlying 
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population, which is mostly similar to the populations of the sources used, is described 
in Table 8. 
Table 8: Synthea's Underlying Population 
Patient Type Breast Cancer Only 
Breast Cancer Patient Region United States 
# Of Patients in Population 1,000 
Gender Female 
Range of Time 2007 – 2015, reflects the time 
ranges of utilized datasets. 
Age Range All Ages 
 
Compare Synthea’s Breast Cancer Outputs 
To compare Synthea’s breast cancer outputs, we used the SEERS dataset as our 
real-world source. Because a full statistical analysis to validate all of the components of 
Synthea’s realism would constitute a full project in itself, we instead compared our 
outputs to show association. To comprehensively associate it, we analyzed the following 
three components of Synthea’s breast cancer outputs with the SEERS data. 
1. Show a close association between Synthea’s breast cancer stage-at-diagnosis 
incidence with real data. 
2. Compare the survival rate by-stage of diagnosis with real data. 
3. Compare the overall survival rate with real data. 
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1. Show a Close Association Between Synthea’s Breast Cancer Staging Incidences with 
Real Data. 
 Synthea’s breast cancer module assigns patients staging based on the TNM 
staging system in which stages are split into subcategories. For instance, Stage I has 
subcategories of IA and IB [44]. However, the data we obtained about the incidence and 
rates of staging in the real population is based on different categorizations. These 
categories include macro-stages and location-based metrics [45]. Macro-staging is 
simply converting substages to its overall stage, such as Stage IA and IB being subsets of 
Stage I. Location-based staging describes where in the body the breast cancer has 
metastasized and includes the stages localized, regional, and distant. Because Synthea’s 
breast cancer staging system was not directly compatible with the staging system of the 
SEERS data, we had to convert Synthea’s output to match it. Based on the Susan G. 
Komen Organization’s comparisons between the different staging categorizations, we 
were able to make the following conversions from Synthea’s TNM staging to the staging 
of the real data in Table 9 [45]. 
Table 9: Conversion from Synthea Staging to Location and Macro Staging 
Synthea’s Staging Output Location Staging Macro Staging 
Stage IA Localized Stage I 
Stage IB 
Stage IIA Stage II 
Stage IIB Regional 
Stage IIIA Stage III 
Stage IIIB 
Stage IIIC 
Stage IV Distant Stage IV 
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 Based on the data output by Synthea, we were able to convert Synthea’s staging to 
Location-Based and macro staging. In a 1000 population simulation, in which patients 
received all treatment they needed, we generated and aggregated the following staging 
data in Table 10. 
Table 10: Synthea's Output of Staging Incidence and Survival Rates of Fully Insured Breast Cancer Patients 
Synthea Output Data 
Synthea's Staging Output Conversion to Macro Staging Conversion to Location Staging 
Stage # of Cases 
# 
Survivors 
# 
Deaths 
Macro 
Stage 
# of 
Cases 
# 
Survivors 
# 
Deaths 
Location 
Stage 
# of 
Cases 
# 
Survivors 
# 
Deaths 
                        
Stage 
IA 467 463 4 Stage 
I 479 475 4 
Localized 666 645 21 Stage IB 12 12 0 
Stage 
IIA 187 170 17 Stage 
II 303 282 21 Stage 
IIB 116 112 4 
Regional 282 230 52 
Stage 
IIIA 
141 97 44 
Stage 
III 166 118 48 
Stage 
IIIB 0 0 0 
Stage 
IIIC 25 21 4 
Stage 
IV 52 16 36 
Stage 
IV 52 16 36 Distant 52 16 36 
                        
Overall 1000 891 109   1000 891 109   1000 891 109 
 
Table 10 displays the incidence of each of the stages as defined by Synthea as well 
as their conversions to Location and Macro staging. It also includes the number of 
survivors and death of each stage-at-diagnosis. With the Synthea output data in hand, 
the next step was to compare the number of cases of individual staging and survival 
rates with real data. 
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 In comparing the percentage of cases per stage, we used the location staging 
method because of the consistent data verifying what its incidence should be. With the 
data found, we were able to create the following chart describing the real-world 
incidences of stages in Table 11. 
 
Table 11: Percentage of Incidences of Real-World Location Stages 
 Real Data 
Location Stage 
Percent Per 
Stage 
Survival Rate 
     
Localized (Stage I - IIA) 62.00% 98.80% 
Regional (Stage IIB - IIIC) 30.00% 85.50% 
Distant (Stage IV) 6.00% 27.40% 
Unknown 2.00% X 
      
Overall X 89.90% 
  
Based on these real-world percentages, we needed to compare them to Synthea’s 
percentages-by-stage. We calculated how Synthea’s output resulted in the incidence of 
staging throughout the population by dividing the number of patients with each stage-
at-diagnosis by the total number of patients (which was 1000). Through this data 
analysis, we created the following chart which compares Synthea’s data percentages 
with the real data in Table 12. 
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Table 12: Comparison of Synthea Output to Real Data of Staging Incidences 
Synthea to Real Data Comparison 
 Real Data Synthea Results 
Location Stage 
Percent Per 
Stage 
Survival 
Rate 
Percent Per 
Stage 
Survival 
Rate 
          
Localized (Stage I - IIA) 62.00% 98.80% 66.60% 96.85% 
Regional (Stage IIB - IIIC) 30.00% 85.50% 28.20% 81.56% 
Distant (Stage IV) 6.00% 27.40% 5.20% 30.77% 
          
Overall X 89.90% X 89.10% 
  
In comparing Synthea’s data with the real data, we found that there was a 
consistent alignment between the distribution of stages-at-diagnosis. The greatest 
difference comes from the Localized stage where the real data shows that 62% of 
patients should be diagnosed with it while 66.6% of Synthea patients were. This marks 
the most extreme difference at 4.6%. The percentage of Regional Staging cases was very 
consistent with only a difference of 1.8%. Distant staging was the most accurate with a 
percentage of cases difference of only 0.8%. A chart displaying the comparison of 
Synthea’s staging incidences with the real-world incidence is displayed in Figure 7. 
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Figure 7: Comparison of Staging Incidences in Synthea and Real Data 
 
2. Comparing Survival Rates By Stage-at-Diagnosis 
 Using the same Synthea dataset, we were also able to compare Synthea’s outputs 
about survival rates with the information that the SEERS dataset held. Again, by using 
the data output by Synthea in Table 2, we were able to detail the survival rates of each 
stage output by Synthea. With the SEERS data we obtained, we were able to compare 
the percentages of Synthea’s survival rates, based on 1000 patients, with the real-world 
ones. The percentage breakdown data is displayed in Table 13. 
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Table 13: Comparison of Survival Rates by Stage between Synthea and Real Data 
Synthea to Real Data Comparison 
 Real Data Synthea Results 
 Percent Per 
Stage 
Survival 
Rate 
Percent Per 
Stage 
Survival 
Rate 
          
Stage I  X 99.00% 47.90% 99.16% 
Stage II  X 93.00% 30.30% 93.07% 
Stage III  X 72.00% 16.60% 71.08% 
Stage IV  X 22.00% 5.20% 30.77% 
          
Localized (Stage I - IIa) 62.00% 98.80% 66.60% 96.85% 
Regional (Stage IIb - IIIc) 30.00% 85.50% 28.20% 81.56% 
Distant (Stage IV) 6.00% 27.40% 5.20% 30.77% 
          
Overall X 89.90% X 89.10% 
 
 As you can see, we were able to compare Synthea’s data with the real data across 
two metrics of staging: both Location Staging and Macro-Staging. The survival rate 
comparisons of Synthea’s stages I – III were very consistent the real data, all varying by 
less than 1%. However, Stage IV’s survival rates differed by 8.77% with Synthea 
outputting a 30.77% survival rate and the real data displaying a 22% survival rate. In 
comparing the Location staging, Localized was consistent within 1.95% and Regional 
was consistent within 3.94%. Interestingly, the Distant Stage, which is essentially the 
same as Stage IV, has a difference of only 3.33% between Synthea and the real data. This 
exact same metric, defined as Stage IV, has the 8.77% difference mentioned above. It is 
possible in this case, then, that different sources have different measurements for 
staging. Most are consistent, however, with the exception of Stage IV and Distant. 
Overall, Synthea produced very consistent survival rate by stage outputs with the real 
data. 
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3. Comparing the Overall Survival Rate 
 Again using Table 5 and the same 1000 patient simulations, it is clear to see that 
the overall survival rate output by Synthea is highly consistent with the real data. In the 
real data, it is shown that the overall survival rate of a population with breast cancer is 
89.90%. Synthea’s output is just 0.8% different at 89.10%. 
 We also included a year-by-year breakdown of how Synthea’s overall breast 
cancer survival rates compared with the SEER data, as seen in Figure 8. Synthea’s 
inputs are based on modern data, which is reflected by the fact that Synthea’s outputs 
match up with the SEER data in the most recent time frame. Although there is overlap 
from 1990-2004, we expect that this is a coincidence because Synthea does not change 
based on the year and is exclusively based on recent survival rate data. Most likely, the 
discrepancy is caused by the fact that, at each of the year-ranges, there is a smaller 
sample size than the 1000 patient overall population, leading to more easily skewed 
data. 
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Figure 8: Yearly Survival Rates in Synthea Compared to SEER Data 
 
Compare Synthea’s Loss-Of-Care Impacts 
 To implement the impact that loss-of-care has on a breast cancer patient’s 
prognosis, we first needed to find data showing the survival rate of uninsured breast 
cancer patients. The study, Breast Cancer Stage Variation and Survival in association 
with insurance status and socioeconomic factors in US women aged 18-64 years Old, 
provides information on the survival rates of uninsured breast cancer patients, based on 
an analysis of SEERS data. The study found that uninsured breast cancer patients were 
60% more likely to die than insured ones. While the overall survival rate of breast 
cancer patients is 89.9%, the study found that the survival rate of uninsured patients 
was 80.4%. 
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 For Synthea to output data consistent with a real-world survival rate for 
uninsured patients of 80.4%, we needed to implement a feature where loss-of-care 
increased a person’s likelihood of death. As described in the methodology, when a 
person has untreated treatments, they will have a certain percent chance of death. 
 With the implementation of this potential death due to loss-of-care feature, we 
needed to tune the probability of death until it resulted in an overall survival rate of 
approximately 80.4%. We started by simply giving a patient a 60% chance of death if 
some treatment went uncovered, however this resulted in far too low survival rates of 
around 56%. By continually tuning and altering this percent of death number, and 
testing simulation outputs, we eventually tuned the data to output an overall survival 
rate of 81% for uninsured patients. Table 14 shows the comparison of the uninsured 
patients Synthea outputted in a 1000 population simulation with the real data that it 
should reflect. 
 
Table 14: Comparison of Uninsured Patient Survival Rates Between Synthea and Real Data 
Synthea to Real Data Comparison (Uninsured Patients) 
 Real Data Synthea Data 
 Survival Rate Survival Rate 
      
Stage I X 93.21% 
Stage II X 85.40% 
Stage III X 62.79% 
Stage IV X 23.44% 
      
Localized (Stage I - IIA) X 90.94% 
Regional (Stage IIB - IIIc) X 71.96% 
Distant (Stage IV) X 23.44% 
      
Overall 80.40% 81.00% 
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 With a difference of just 0.6% between Synthea’s uninsured survival rate and the 
real data’s survival rate, there is clearly a close association between the two. 
 
Compare Synthea’s Tuned Health Insurance Levels 
 The final step in showing that our hypotheses, and the data they are based on,  
are accurate, was ensuring that the distribution of health insurance reflected real-world 
levels. To achieve this goal, we needed to find out what pricing for private insurance 
would result in the correct insurance outputs. We started with a baseline of a $1000 
deductible, $55 copay, and $1000 monthly premium. Because people receive private 
insurance based on their incomes and its affordability, we needed to tune these expenses 
until Synthea’s output reflected the real data. 
 When tuning the data, we found that we did not have to change anything 
regarding Medicare’s insurance incidence rates. Because Medicare qualification is based 
on 1.33 * the federal poverty rate, with the poverty rate set at $11000 per year, there was 
already a set baseline for its cost. In addition, because each person’s individual incomes 
is generated based on real economic probability and data, it was only natural that the 
Medicare incidence, based on each person’s income, would follow reality. 
 The only data point we had to tune was the cost of private insurance. Through the 
process, we settled on its deductible costing $1000, its copay set at $55 and a monthly 
premium of $1400. In evaluating the percentage distributions of how much insurance 
coverage was available during the simulation, we used the payer_transitions.csv output 
file which lists every person’s insurance company for every year. We simply summed up 
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the total number of years of coverage for each insurance and used it as a divisor for the 
number of years that each of the three insurance categories had (Private/Medicaid/No 
Insurance). 
 We first started by gathering this data in Table 15, which displays each of these 
categories’ number of years of use. 
Table 15: Number of Years Each Insurance Category Was Utilized in Synthea 
Synthea Output 
Insurance 
Number of Years of 
Insurance Use 
Private Insurance 72850 
Medicaid 9758 
No Insurance 2017 
Total Years Lived 84625 
 
 The next step was converting this data to percentages and comparing it to the real 
data in Table 16. 
Table 16: Comparison of Percent of Utilization of Insurance Categories Between Synthea and Real Data 
 Real Data Synthea Data 
Insurance 
Percentage 
breakdown of each 
insurance status 
Percentage 
breakdown of each 
insurance status 
Private 
Insurance 86.00% 86.09% 
Medicaid 11.60% 11.53% 
No Insurance 2.40% 2.38% 
 
 As you can see, Synthea’s outputs are all within 0.1% of the real data for each 
insurance category. 
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5.2 Result 2: The Survival Rate of Uninsured Patients is Lower 
than Insured Patients. 
 With Synthea’s outputs shown to reflect real data, we were able to make 
conclusions based on Synthea’s data with a reasonable degree of certainty of their 
accuracy. Our hypothesis to test was whether there is a significant decrease in the 
survival rates of uninsured breast cancer patients verses insured ones. The statistical 
formatting to analyze this hypothesis is as follows: 
 H0 : μI <= μU 
 H1 : μI > μU 
o Where μI is the average survival rate of insured breast cancer patients 
and μU is the average survival rate of uninsured breast cancer Patients. 
To test this hypothesis and either reject or fail to reject the null hypothesis, we 
used a two-sample one-tailed proportion p-test. The two samples were from Synthea 
datasets that were previously generated: The population where every patient had 
insurance and the population where no patients had insurance. The overall survival 
rates output by Synthea for each was as follows: 
 Insured breast cancer patient survival rate (μI):  89.10% 
 Uninsured breast cancer patient survival rate (μU): 81.00% 
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Table 17: Comparison of Overall Survival Rates of Uninsured and Insured Breast Cancer Populations in Synthea 
Synthea Insured Vs. Uninsured Survival Rates 
 
Insured 
Patients 
Uninsured 
Patients 
# Survivors 891 810 
# Deaths 109 190 
Total # Patients 1000 1000 
Overall Survival 
Rate 89.10% 81.00% 
 
 Figure 9 displays comparisons of the survival rates by stage of insured and 
uninsured patients in Synthea. Although each bar comparison may seem relatively 
similar, there are actually percentage gaps of around 10% for each survival rate 
comparison. 
 
Figure 9: Comparison of Survival Rates By Stage of Insured and Uninsured Patients in Synthea 
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To complete a statistical analysis with a two-sample one-tailed proportion p-test, 
we used the following formulas, using a Z-Score as our test statistic. Our statistical test 
was based on a comparison between the overall survival rate of insured and uninsured 
breast cancer patients.  
 The first step was to calculate the pooled sample proportion (𝜌): 
o 𝜌 =
×   ×
 
 Where nI is the sample size of the insured population and nU is the 
sample size of the uninsured population. 
o 𝜌 =
. ×   . ×
 
o 𝜌 =  0.8505 
 Next, we needed to calculate the Standard Error (SE): 
o 𝑆𝐸 = 𝜌 × (1 − 𝜌) × 1 𝑛 + 1 𝑛  
o 𝑆𝐸 = 0.8505 × (0.1495) × 1 1000 +
1
1000  
o 𝑆𝐸 = 0.01595 
 Finally, we calculated the test-statistic Z-Score (z): 
o 𝑧 =  
o 𝑧 =
. .
.
 
o 𝑧 = 5.0783 
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With a Z-Score test statistic of 5.0783, we can locate it along the standard normal 
distribution, providing us with a p-value of less than 0.00001. Because the p-value is 
less than the significance level of 0.01, we are able to reject the null hypothesis and 
conclude that breast cancer patients with health insurance have a higher 
survival rate than those without insurance. 
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6 Conclusion 
 The goal of this MQP was to implement health insurance and loss-of-care 
modules in Synthea. Although we chose to limit our initial scope to breast cancer 
patients, we have laid the groundwork for further research in this area for more 
diseases, populations, and insurance types. We also limited our research to analyzing 
survival rates, however future research should expand to analyze the impacts of loss-of-
care due to healthcare and insurance expenses to Quality of Life metrics. Quality of Life 
allows for the analysis of a range of burdens and impacts of conditions and loss-of-care 
as opposed to simply death. We initially planned for Quality of Life to be the focus of 
this MQP, however we found that survival rates made more sense for breast cancer 
patients so we could compare our data with reality. We even implemented much of the 
necessary Quality of Life code in Synthea so, for a continuation of this research, it could 
be expanded upon and used. 
 Another aspect of the MQP included generating populations with levels of 
insurance that reflect real life. We detailed this in the Methodology and Results sections, 
but left it as a contribution to Synthea rather than as a part of our hypotheses. Our 
implementation of insurance levels was shown to be reflective of real life. These 
insurance levels could be used for simulating populations to test changing insurance 
variables to analyze what policies and pricing could affect the overall health of the 
population. It would be fascinating to analyze how factors such as doubling or halving 
the cost of insurance or qualifications for Medicaid could impact health. Or, what if you 
made Medicaid free and universal? Or turned private insurance into a utility good? 
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Synthea outputs the revenues and expenses of every insurance company in the 
simulation, so you could even analyze the economic impact and cost-effectiveness. Lots 
of fascinating research opportunity is available here – made possible by Synthea and the 
ability to simulate and tweak insurance variables to see its impacts. 
 We have taken the first steps in implementing and analyzing health insurance 
and its impacts in Synthea. Simulating simply health data, as Synthea did before, is 
highly useful because of the barriers to access of real data. For more realistic outputs, 
Synthea needed health insurance because of its integral role in the healthcare system 
and health policy of the United States. We hope that this MQP, especially its 
contributions to the capabilities of Synthea, can be expanded on for complete analyses 
of different insurance costs and policies so that research and analysis could be further 
conducted on how health insurance impacts the health of a population. 
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